• 1147 Citations
  • 19 Scopus h-Index
20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion

Waddle, M., Irvin, M., Gupta, E., Gibbs, M., Kakar, T. S., Gannon, N. A., Arthurs, J. R., Fischer, D. L. & Ailawadhi, S., May 16 2017, (Accepted/In press) In : Chemotherapy. p. 295-300 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., Mc Williams, R. R., Moreno Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

1 Scopus citations

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Du, Z., Weinhold, N., Song, G. C., Rand, K. A., Van Den Berg, D. J., Hwang, A. E., Sheng, X., Hom, V., Ailawadhi, S., Nooka, A. K., Singhal, S., Pawlish, K., Peters, E. S., Bock, C., Mohrbacher, A., Stram, A., Berndt, S. I., Blot, W. J., Casey, G., Stevens, V. L. & 50 others, Kittles, R., Goodman, P. J., Diver, W. R., Hennis, A., Nemesure, B., Klein, E. A., Rybicki, B. A., Stanford, J. L., Witte, J. S., Signorello, L., John, E. M., Bernstein, L., Stroup, A. M., Stephens, O. W., Zangari, M., Van Rhee, F., Olshan, A., Zheng, W., Hu, J. J., Ziegler, R., Nyante, S. J., Ingles, S. A., Press, M. F., Carpten, J. D., Chanock, S. J., Mehta, J., Colditz, G. A., Wolf, J., Martin, T. G., Tomasson, M., Fiala, M. A., Terebelo, H., Janakiraman, N., Kolonel, L., Anderson, K. C., Le Marchand, L., Auclair, D., Chiu, B. C. H., Ziv, E., Stram, D., Vij, R., Bernal-Mizrachi, L., Morgan, G. J., Zonder, J. A., Huff, C. A., Lonial, S., Orlowski, R. Z., Conti, D. V., Haiman, C. A. & Cozen, W., Jan 14 2020, In : Blood Advances. 4, 1, p. 181-190 10 p.

Research output: Contribution to journalArticle

Open Access

A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci

Rand, K. A., Song, C., Dean, E., Serie, D. J., Curtin, K., Sheng, X., Hu, D., Huff, C. A., Bernal-Mizrachi, L., Tomasson, H. M., Ailawadhi, S., Singhal, S., Pawlish, K., Peters, E. S., Bock, C. H., Stram, A., Van Den Berg, D. J., Edlund, C. K., Conti, D. V., Zimmerman, T. & 82 others, Hwang, A. E., Huntsman, S., Graff, J., Nooka, A., Kong, Y., Pregja, S. L., Berndt, S. I., Blot, W. J., Carpten, J., Casey, G., Chu, L., Diver, W. R., Stevens, V. L., Lieber, M. R., Goodman, P. J., Hennis, A. J. M., Hsing, A. W., Mehta, J., Kittles, R. A., Kolb, S., Klein, E. A., Leske, C., Murphy, A. B., Nemesure, B., Neslund-Dudas, C., Strom, S. S., Vij, R., Rybicki, B. A., Stanford, J. L., Signorello, L. B., Witte, J. S., Ambrosone, C. B., Bhatti, P., John, E. M., Bernstein, L., Zheng, W., Olshan, A. F., Hu, J. J., Ziegler, R. G., Nyante, S. J., Bandera, E. V., Birmann, B. M., Ingles, S. A., Press, M. F., Atanackovic, D., Glenn, M. J., Cannon-Albright, L. A., Jones, B., Tricot, G., Martin, T. G., Kumar, S. K., Wolf, J. L., Deming Halverson, S. L., Rothman, N., Brooks-Wilson, A. R., Rajkumar, S. V., Kolonel, L. N., Chanock, S. J., Slager, S. L., Severson, R. K., Janakiraman, N., Terebelo, H. R., Brown, E. E., De Roos, A. J., Mohrbacher, A. F., Colditz, G. A., Giles, G. G., Spinelli, J. J., Chiu, B. C., Munshi, N. C., Anderson, K. C., Levy, J., Zonder, J. A., Orlowski, R. Z., Lonial, S., Camp, N. J., Vachon, C. M., Ziv, E., Stram, D. O., Hazelett, D. J., Haiman, C. A. & Cozen, W., Dec 1 2016, In : Cancer Epidemiology Biomarkers and Prevention. 25, 12, p. 1609-1618 10 p.

Research output: Contribution to journalArticle

7 Scopus citations

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

Ailawadhi, S., Kelly, K. R., Vescio, R. A., Jagannath, S., Wolf, J., Gharibo, M., Sher, T., Bojanini, L., Kirby, M. & Chanan-Khan, A., Jan 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 1, p. 29-34 6 p.

Research output: Contribution to journalArticle

8 Scopus citations

A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients

Sher, T., Ailawadhi, S., Miller, K. C., Manfredi, D., Wood, M., Tan, W., Wilding, G., Czuczman, M. S., Hernandez-Ilizaliturri, F. J., Hong, F., Sood, R., Soniwala, S., Lawrence, W., Jamshed, S., Masood, A., Iancu, D., Lee, K. & Chanan-Khan, A., Jul 2011, In : British journal of haematology. 154, 1, p. 104-110 7 p.

Research output: Contribution to journalArticle

11 Scopus citations

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

15 Scopus citations

Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: Results of a phase II clinical trial

Chanan-Khan, A., Miller, K. C., Musial, L., Padmanabhan, S., Yu, J., Ailawadhi, S., Sher, T., Mohr, A., Bernstein, Z. P., Barcos, M., Patel, M., Iancu, D., Lee, K. & Czuczman, M. S., Aug 17 2009, In : Leukemia and Lymphoma. 50, 7, p. 1096-1101 6 p.

Research output: Contribution to journalArticle

26 Scopus citations

Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma

Ailawadhi, S., Miecznikowski, J., Gaile, D. P., Wang, D., Sher, T., Mulligan, G., Bryant, B., Wilding, G. E., Mashtare, T., Stein, L., Masood, A., Neuwirth, R., Lee, K. P. & Chanan-Khan, A., Jun 1 2012, In : Leukemia and Lymphoma. 53, 6, p. 1174-1182 9 p.

Research output: Contribution to journalArticle

14 Scopus citations

Chemotherapy-induced carcinoembryonic antigen surge in patients with metastatic colorectal cancer

Ailawadhi, S., Sunga, A., Rajput, A., Yang, G. Y., Smith, J. & Fakih, M., Mar 1 2006, In : Oncology. 70, 1, p. 49-53 5 p.

Research output: Contribution to journalArticle

26 Scopus citations

Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells

Paulus, A., Akhtar, S., Caulfield, T., Samuel, K., Yousaf, H., Bashir, Y., Paulus, S. M., Tran, D., Hudec, R., Cogen, D., Jiang, J., Edenfield, B., Novak, A. J., Ansell, S. M., Witzig, T. E., Martin, P., Coleman, M., Roy, V., Ailawadhi, S., Chitta, K. & 2 others, Linder, S. & Chanan Khan, A. A., Nov 4 2016, In : Blood Cancer Journal. 6, 11, e492.

Research output: Contribution to journalArticle

20 Scopus citations

Connect MM Registry as a national reference for United States multiple myeloma patients

on behalf of Connect MM Registry Investigators, Jan 1 2020, In : Cancer medicine. 9, 1, p. 35-42 8 p.

Research output: Contribution to journalArticle

Open Access

Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignancies

Shreders, A. J., Niazi, S. K., Hodge, D. O., Chimato, N. T., Kureti, M., Kirla, N., Agrawal, A., Swaika, A., Gustetic, E., Foster, R., Nelson, K. A., Jani, P., Chanan Khan, A. A. & Ailawadhi, S., Dec 7 2017, (Accepted/In press) In : Annals of Hematology. p. 1-10 10 p.

Research output: Contribution to journalArticle

3 Scopus citations

Cost-effectiveness of carfilzomib plus dexamethasone compared with bortezomib plus dexamethasone for patients with relapsed or refractory multiple myeloma in the United States

Jakubowiak, A. J., Houisse, I., Májer, I., Benedict, Á., Campioni, M., Panjabi, S. & Ailawadhi, S., Dec 2 2017, In : Expert Review of Hematology. 10, 12, p. 1107-1119 13 p.

Research output: Contribution to journalArticle

11 Scopus citations

Cost-effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients with Heavily Pretreated Relapsed-refractory Multiple Myeloma in the United States

Pelligra, C. G., Parikh, K., Guo, S., Chandler, C., Mouro, J., Abouzaid, S. & Ailawadhi, S., 2017, (Accepted/In press) In : Clinical Therapeutics.

Research output: Contribution to journalArticle

11 Scopus citations

Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma

Ailawadhi, S., DerSarkissian, M., Duh, M. S., Lafeuille, M. H., Posner, G., Ralston, S., Zagadailov, E., Ba-Mancini, A. & Rifkin, R., Mar 2019, In : Clinical therapeutics. 41, 3, p. 477-493.e7

Research output: Contribution to journalArticle

2 Scopus citations

Deep sequencing reveals lack of a clonal relationship between a metachronous classical hodgkin and diffuse large B-cell lymphoma

Siddiqi, I. N., Ailawadhi, S., Huang, Q., Shibata, R. K., Kang, H. & Shibata, D., Jun 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 3, p. e87-e93

Research output: Contribution to journalArticle

2 Scopus citations

Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute- Waldenström Macroglobulinemia 1

Chitta, K. S., Paulus, A., Ailawadhi, S., Foster, B. A., Moser, M. T., Starostik, P., Masood, A., Sher, T., Miller, K. C., Iancu, D. M., Conroy, J., Nowak, N. J., Sait, S. N., Personett, D. A., Coleman, M., Furman, R. R., Martin, P., Ansell, S. M., Lee, K. & Chanan-Khan, A. A., Feb 1 2013, In : Leukemia and Lymphoma. 54, 2, p. 387-396 10 p.

Research output: Contribution to journalArticle

16 Scopus citations

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

Paludo, J., Abeykoon, J. P., Kumar, S., Shreders, A., Ailawadhi, S., Gertz, M. A., Kourelis, T., King, R. L., Reeder, C. B., Leung, N., Kyle, R. A., Buadi, F. K., Habermann, T. M., Dingli, D., Witzig, T. E., Dispenzieri, A., Lacy, M. Q., Go, R. S., Lin, Y., Gonsalves, W. I. & 5 others, Warsame, R., Lust, J. A., Rajkumar, S. V., Ansell, S. M. & Kapoor, P., Oct 2017, In : British journal of haematology. 179, 1, p. 98-105 8 p.

Research output: Contribution to journalArticle

7 Scopus citations
50 Scopus citations

Disease and outcome disparities in multiple myeloma: Exploring the role of race/ethnicity in the Cooperative Group clinical trials

Ailawadhi, S., Jacobus, S., Sexton, R., Stewart, A. K., Dispenzieri, A., Hussein, M. A., Zonder, J. A., Crowley, J., Hoering, A., Barlogie, B., Orlowski, R. Z. & Rajkumar, S. V., Jul 1 2018, In : Blood Cancer Journal. 8, 7, 67.

Research output: Contribution to journalArticle

12 Scopus citations

Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner

Masood, A., Chitta, K., Paulus, A., Khan, A. N. H., Sher, T., Ersing, N., Miller, K. C., Manfredi, D., Ailawadhi, S., Borrelo, I., Lee, K. P. & Chanan-Khan, A. A., Apr 1 2012, In : British journal of haematology. 157, 1, p. 59-66 8 p.

Research output: Contribution to journalArticle

19 Scopus citations

Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?

Ailawadhi, S., Bhatia, K., Aulakh, S., Meghji, Z. & Chanan Khan, A. A., Jun 19 2017, (Accepted/In press) In : Current Hematologic Malignancy Reports. p. 1-8 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

Erlotinib for metastatic non-small-cell lung cancer: First-, second- or third-line setting - Does it matter? A single-institution experience

Ailawadhi, S., Derby, L., Natarajan, R., Fetterly, G., Reid, M. & Ramnath, N., Feb 1 2009, In : Oncology. 76, 2, p. 85-90 6 p.

Research output: Contribution to journalArticle

9 Scopus citations

Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma

Ailawadhi, S., Abdelhalim, A. N., Derby, L., Mashtare, T. L., Miller, K. C., Wilding, G. E., Alberico, R. A., Gottlieb, R., Klippenstein, D. L., Lee, K. & Chanan-Khan, A. A., Jan 1 2010, In : Cancer. 116, 1, p. 84-92 9 p.

Research output: Contribution to journalArticle

15 Scopus citations

Extramedullary solitary plasmacytoma: Demonstrating the role of 18F-FDG PET imaging

Gautam, A., Sahu, K. K., Alamgir, A., Siddiqi, I. & Ailawadhi, S., Apr 1 2017, In : Journal of Clinical and Diagnostic Research. 11, 4, p. XD01-XD03

Research output: Contribution to journalArticle

8 Scopus citations

Financial burden after allogeneic hematopoietic cell transplantation: A qualitative analysis from the patient's perspective

Kim, W., McNulty, J., Chang, Y. H., Weise, M., Hashmi, S., Ailawadhi, S. & Khera, N. D., Sep 4 2015, In : Bone Marrow Transplantation. 50, 9, p. 1259-1261 3 p.

Research output: Contribution to journalArticle

14 Scopus citations

Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events

Ailawadhi, S., Medhekar, R., Princic, N., Fowler, R., Tran, O., Bhowmik, D. & Panjabi, S., Jan 1 2019, (Accepted/In press) In : Journal of Oncology Pharmacy Practice.

Research output: Contribution to journalArticle

IAP antagonists induce anti-tumor immunity in multiple myeloma

Chesi, M., Mirza, N. N., Garbitt, V. M., Sharik, M. E., Dueck, A., Asmann, Y., Akhmetzyanova, I., Kosiorek, H. E., Calcinotto, A., Riggs, D. L., Keane, N., Ahmann, G. J., Morrison, K. M., Fonseca, R., Lacy, M., Dingli, D. M., Kumar, S. K., Ailawadhi, S., Dispenzieri, A., Buadi, F. & 7 others, Gertz, M., Reeder, C. B., Lin, Y., Chanan Khan, A. A., Stewart, A. K., Fooksman, D. & Bergsagel, P. L., Dec 1 2016, In : Nature Medicine. 22, 12, p. 1411-1420 10 p.

Research output: Contribution to journalArticle

59 Scopus citations

Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: Potential biological and therapeutic implications

Paulus, A., Chitta, K. S., Wallace, P. K., Advani, P. P., Akhtar, S., Kuranz-Blake, M., Ailawadhi, S. & Chanan Khan, A. A., Apr 8 2015, In : PLoS One. 10, 4, e0122338.

Research output: Contribution to journalArticle

8 Scopus citations

Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

Ailawadhi, S., Advani, P., Yang, D., Ghosh, R., Swaika, A., Roy, V., Foran, J. M., Colon-Otero, G. & Chanan Khan, A. A., Feb 15 2016, In : Cancer. 122, 4, p. 618-625 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Impact of Depression and Anxiety on Opioid Use in Hospitalized Hematopoietic Cell Transplantation Recipients

Iqbal, M., Spaulding, A., Niazi, S. K., Wood, C., Ahmed, S., Jani, P., Kharfan-Dabaja, M. A., Ayala, E., Manochakian, R., Ames, S. C., Paulus, A., Ailawadhi, S., Roy, V., Chanan-Khan, A. & Sher, T., Jan 1 2020, (Accepted/In press) In : Psychosomatics.

Research output: Contribution to journalArticle

Impact of initial treatment (tx) on HRQoL and outcomes in patients (pts) with newly diagnosed multiple myeloma (NDMM) without intent for immediate transplant (SCT): Results from the Connect® MM registry

Abonour, R., Rifkin, R. M., Gasparetto, C., Toomey, K., Durie, B. G. M., Hardin, J. W., Terebelo, H. R., Jagannath, S., Narang, M., Ailawadhi, S., Srinivasan, S., Kitali, A., Agarwal, A. & Wagner, L., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii360

Research output: Contribution to journalArticle

Open Access

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Niazi, S. K., Frank, R. D., Sharma, M., Roy, V., Ames, S. C., Rummans, T. A., Spaulding, A., Sher, T., Ailawadhi, M., Bhatia, K., Ahmed, S., Tan, W., Chanan-Khan, A. & Ailawadhi, S., May 22 2018, In : Blood Advances. 2, 10, p. 1120-1128 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma

Jagannath, S., Heffner, L. T., Ailawadhi, S., Munshi, N. C., Zimmerman, T. M., Rosenblatt, J., Lonial, S., Chanan Khan, A. A., Ruehle, M., Rharbaoui, F., Haeder, T., Wartenberg-Demand, A. & Anderson, K. C., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

9 Scopus citations

Influence of Sociodemographic Factors on Treatment Decisions in Non–Small-Cell Lung Cancer

Duma, N., Idossa, D. W., Durani, U., Frank, R. D., Paludo, J., Westin, G., Lou, Y., Mansfield, A. S., Adjei, A. A., Go, R. S. & Ailawadhi, S., May 2020, In : Clinical lung cancer. 21, 3, p. e115-e129

Research output: Contribution to journalArticle

Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma

Ailawadhi, S., Nagase, H., Khoury, T., Yu, J., Tan, D., Black, J., Brattain, M. & Javle, M., Jul 1 2007, In : Hepato-Gastroenterology. 54, 77, p. 1339-1344 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

Marantic endocarditis associated with T-Cell large granular lymphocytic leukemia: First report of its occurrence with a lymphoproliferative malignancy in adults

Ahmed, S., Jani, P., Yamani, M. H., Ailawadhi, S., Alegria, V. R. & Ailawadhi, M., Oct 1 2018, In : Journal of Oncology Practice. 14, 10, p. 625-627 3 p.

Research output: Contribution to journalArticle

Molecular modeling and functional analysis of exome sequencing-derived variants of unknown significance identify a novel, constitutively active FGFR2 mutant in cholangiocarcinoma

Egan, J. B., Marks, D. L., Hogenson, T. L., Vrabel, A. M., Sigafoos, A. N., Tolosa, E. J., Carr, R. M., Safgren, S. L., Hesles, E. E., Almada, L. L., Romecin-Duran, P. A., Iguchi, E., Ala'Aldeen, A., Kocher, J. P. A., Oliver, G. R., Prodduturi, N., Mead, D. W., Hossain, A., Huneke, N. E., Tagtow, C. M. & 43 others, Ailawadhi, S., Ansell, S. M., Banck, M. S., Bryce, A. H., Carballido, E. M., Chanan-Khan, A. A., Curtis, K. K., Resnik, E., Gawryletz, C. D., Go, R. S., Halfdanarson, T. R., Ho, T. H., Joseph, R. W., Kapoor, P., Mansfield, A. S., Meurice, N., Rao, A. A. N., Nowakowski, G. S., Pardanani, A., Parikh, S. A., Cheville, J. C., Feldman, A. L., Ramanathan, R. K., Robinson, S. I., Tibes, R., Finnes, H. D., McCormick, J. B., McWilliams, R. R., Jatoi, A., Patnaik, M. M., Silva, A. C., Wieben, E. D., McAllister, T. M., Rumilla, K. M., Kerr, S. E., Lazaridis, K. N., Farrugia, G., Keith Stewart, A., Clark, K. J., Kennedy, E. J., Klee, E. W., Borad, M. J. & Fernandez-Zapico, M. E., Jan 1 2017, In : JCO Precision Oncology. 2017, 1, p. 1-13 13 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Monoclonal antibody utilization characteristics in patients with multiple myeloma

Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan Khan, A. A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

Research output: Contribution to journalArticle

Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia

Chitta, K., Paulus, A., Caulfield, T., Akhtar, S., Blake, M. K. K., Ailawadhi, S., Knight, J., Heckman, M. G., Pinkerton, A. & Chanan Khan, A. A., Jan 1 2014, In : Blood Cancer Journal. 4, 11, e260.

Research output: Contribution to journalArticle

13 Scopus citations

Outcome disparities among ethnic subgroups of waldenström's macroglobulinemia: A population-based study

Ailawadhi, S., Kardosh, A., Yang, D., Cozen, W., Patel, G., Alamgir, M. A. & Chanan-Khan, A. A., Jul 2014, In : Oncology (Switzerland). 86, 5-6, p. 253-262 10 p.

Research output: Contribution to journalArticle

12 Scopus citations

Outcome disparities in multiple myeloma: A SEER-based comparative analysis of ethnic subgroups

Ailawadhi, S., Aldoss, I. T., Yang, D., Razavi, P., Cozen, W., Sher, T. & Chanan-Khan, A., Jul 1 2012, In : British journal of haematology. 158, 1, p. 91-98 8 p.

Research output: Contribution to journalArticle

42 Scopus citations

Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma

Ailawadhi, S., Dholaria, B. R., Khurana, S., Sher, T., Alegria, V., Paulus, A., Ailawadhi, M., Mehta, A., Chanan Khan, A. A. & Roy, V., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Palliative Care Use Among Patients With Solid Cancer Tumors: A National Cancer Data Base Study

Osagiede, O., Colibaseanu, D. T., Spaulding, A., Frank, R. D., Merchea, A., Kelley, S. R., Uitti, R. J. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Journal of Palliative Care.

Research output: Contribution to journalArticle

3 Scopus citations

Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics

Razavi, P., Rand, K. A., Cozen, W., Chanan-Khan, A., Usmani, S. & Ailawadhi, S., Jun 1 2013, In : Blood cancer journal. 3, 6, e121.

Research output: Contribution to journalArticle

35 Scopus citations
11 Scopus citations

Pharmacoeconomic implications of lenalidomide maintenance therapy in multiple myeloma

Kim, M. Y., Sposto, R., Swaika, A., Asano, H., Alamgir, A., Chanan-Khan, A. & Ailawadhi, S., Nov 7 2014, In : Oncology (Switzerland). 87, 4, p. 224-231 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies

Siddiqi, T., Frankel, P., Beumer, J. H., Kiesel, B. F., Christner, S., Ruel, C., Song, J. Y., Chen, R., Kelly, K. R., Ailawadhi, S., Kaesberg, P., Popplewell, L., Puverel, S., Piekarz, R., Forman, S. J. & Newman, E. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle